Overweight and hypertriglyceridemia are risk factors for liver cirrhosis in middle-aged Swedish men

References

• Westwater JO, Fainer D. Liver impairment in the obese. Gastroenterology 1958;34(4):686–93.
   PubMed Web of Science ®Google Scholar
• Zelman S. The liver in obesity. AMA 1952;90(2):141–56.
   Google Scholar
• Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346(16):1221–31.
   PubMed Web of Science ®Google Scholar
• Clark JM, Brancati FL, Diehl AM. Nonalcoholic fatty liver disease. Gastroenterology 2002;122(6):1649–57.
   PubMed Web of Science ®Google Scholar
• Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980;55(7):434–8.
   PubMed Web of Science ®Google Scholar
• Ratziu V, Giral P, Charlotte F, Bruckert E, Thibault V, Theodorou I, Liver fibrosis in overweight patients. Gastroenterology 2000;118(6):1117–23.
   PubMed Web of Science ®Google Scholar
• Knobler H, Schattner A, Zhornicki T, Malnick SD, Keter D, Sokolovskaya N, Fatty liver – an additional and treatable feature of the insulin resistance syndrome. QJM 1999;92(2):73–9.
   PubMedGoogle Scholar
• Teli MR, James OF, Burt AD, Bennett MK, Day CP. The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology 1995;22(6):1714–19.
   PubMed Web of Science ®Google Scholar
• Clark JM, Diehl AM. Defining nonalcoholic fatty liver disease: implications for epidemiologic studies. Gastroenterology 2003;124(1):248–50.
   PubMed Web of Science ®Google Scholar
• Kaczynski J, Hansson G, Wallerstedt S. Diabetes: one of few remarkable differences in clinicopathologic features between cirrhotic and noncirrhotic Swedes with hepatocellular carcinoma. Dig Dis Sci 2006;51(4):796–802.
   PubMed Web of Science ®Google Scholar
• Bellentani S, Saccoccio G, Masutti F, Croce LS, Brandi G, Sasso F, Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 2000;132(2):112–17.
   PubMed Web of Science ®Google Scholar
• McCullough AJ. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. Clin Liver Dis 2004;8(3):521–33.
   PubMedGoogle Scholar
• Hui JM, Kench JG, Chitturi S, Sud A, Farrell GC, Byth K, Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C. Hepatology 2003;38(2):420–7.
   PubMed Web of Science ®Google Scholar
• Angulo P, Keach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999;30(6):1356–62.
   PubMed Web of Science ®Google Scholar
• Dixon JB, Bhathal PS, O'Brien PE. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001;121(1):91–100.
   PubMed Web of Science ®Google Scholar
• Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003;37(4):917–23.
   PubMed Web of Science ®Google Scholar
• Naveau S, Giraud V, Borotto E, Aubert A, Capron F, Chaput JC. Excess weight risk factor for alcoholic liver disease. Hepatology 1997;25(1):108–11.
   PubMed Web of Science ®Google Scholar
• Raynard B, Balian A, Fallik D, Capron F, Bedossa P, Chaput JC, Risk factors of fibrosis in alcohol-induced liver disease. Hepatology 2002;35(3):635–8.
   PubMed Web of Science ®Google Scholar
• Hourigan LF, Macdonald GA, Purdie D, Whitehall VH, Shorthouse C, Clouston A, Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hepatology 1999;29(4):1215–19.
   PubMed Web of Science ®Google Scholar
• Ioannou GN, Weiss NS, Kowdley KV, Dominitz JA. Is obesity a risk factor for cirrhosis-related death or hospitalization? A population-based cohort study. Gastroenterology 2003;125(4):1053–9.
   PubMed Web of Science ®Google Scholar
• Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005;129(1):113–21.
   PubMed Web of Science ®Google Scholar
• Stroffolini T, Sagnelli E, Almasio P, Ferrigno L, Craxi A, Mele A. Characteristics of liver cirrhosis in Italy: results from a multicenter national study. Dig Liver Dis 2004;36(1):56–60.
   PubMedGoogle Scholar
• McCullough AJ, O'Connor JF. Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology. Am J Gastroenterol 1998;93(11):2022–36.
   PubMed Web of Science ®Google Scholar
• Haukeland JW, Lorgen I, Schreiner LT, Frigstad SO, Brandsaeter B, Bjoro K, Incidence rates and causes of cirrhosis in a Norwegian population. Scand J Gastroenterol 2007;42(12):1501–8.
   PubMed Web of Science ®Google Scholar
• Gunnarsdottir SA, Olsson R, Olafsson S, Cariglia N, Westin J, Thjodleifsson B, Liver cirrhosis in Iceland and Sweden: incidence, aetiology and outcomes. Scand J Gastroenterol 2009;44(8):984–93.
   PubMed Web of Science ®Google Scholar
• Tibblin G. High blood pressure in men aged 50 – a population study of men born in 1913. Acta Med Scand 1967;470:1–84.
   Google Scholar
• Carlson LA, Wadstrom LB. Determination of glycerides in blood serum. Clin Chim Acta; Int J Clin Chem 1959;4(2):197–205.
   PubMed Web of Science ®Google Scholar
• Cramér K, Isaksson B. An evaluation of the Theorell method for the determination of total serum cholesterol. Scand J Clin Lab Invest 1959;11(2):213–16.
   Web of Science ®Google Scholar
• Levin K, Linde S. Determination of glucose in blood, cerebrospinal fluid and urine with a new glucose oxidase reagent. Sven Lakartidn 1962;59:3016–26.
   PubMedGoogle Scholar
• Kaczynski J, Hansson G, Wallerstedt S. Incidence of primary liver cancer and aetiological aspects: a study of a defined population from a low-endemicity area. Br J Cancer 1996;73(1):128–32.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Kim HJ, Lee KE, Kim DJ, Kim SK, Ahn CW, Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults. Arch Intern Med 2004;164(19):2169–75.
   PubMedGoogle Scholar
• Lewis GF, Carpentier A, Adeli K, Giacca A. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev 2002;23(2):201–29.
   PubMed Web of Science ®Google Scholar
• Tibblin G. A population study of 50-year-old men. An analysis of the non-participation group. Acta Med Scand 1965;178(4):453–9.
   PubMedGoogle Scholar
• Rantala M, van de Laar MJ. Surveillance and epidemiology of hepatitis B and C in Europe – a review. Euro Surveill 2008;13(21).
   PubMedGoogle Scholar
• Blackberg J, Braconier JH, Widell A, Kidd-Ljunggren K. Long-term outcome of acute hepatitis B and C in an outbreak of hepatitis in 1969–72. Eur J Clin Microbiol Infect Dis 2000;19(1):21–6.
   PubMed Web of Science ®Google Scholar
• Weiland O, Berg JV, Bjorvatn B, Flehmig B, Lundbergh P. Acute viral hepatitis A, B and non-A, non-B in Stockholm in the 1950s and 1970s: a comparison. Infection 1981;9(6):268–74.
   PubMed Web of Science ®Google Scholar
• Kaczynski J, Hansson G, Hermodsson S, Olsson R, Wallerstedt S. Minor role of hepatitis B and C virus infection in the etiology of hepatocellular carcinoma in a low-endemic area. Scand J Gastroenterol 1996;31(8):809–13.
   PubMed Web of Science ®Google Scholar
• Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997;349(9055):825–32.
   PubMed Web of Science ®Google Scholar
• Ostapowicz G, Watson KJ, Locarnini SA, Desmond PV. Role of alcohol in the progression of liver disease caused by hepatitis C virus infection. Hepatology 1998;27(6):1730–5.
   PubMed Web of Science ®Google Scholar
• Welin L, Adlerberth A, Caidahl K, Eriksson H, Hansson PO, Johansson S, Prevalence of cardiovascular risk factors and the metabolic syndrome in middle-aged men and women in Gothenburg, Sweden. BMC Public Health 2008;8(1):403.
   PubMedGoogle Scholar